Heidelberg Pharma AG (HPHA) | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 11/06/2024 at 10:07, 14 days 23 hours ago

Heidelberg Pharma dévoile des données prometteuses sur le HDP-101 à l'ASH 2024

Heidelberg Pharma HDP-101 Myélome Multiple Données Cliniques Technologie ADC
BRIEF

published on 11/06/2024 at 10:07, 14 days 23 hours ago

Heidelberg Pharma Reveals Promising Data on HDP-101 at ASH 2024

Clinical Data Heidelberg Pharma HDP-101 ADC Technology Multiple Myeloma
PRESS RELEASE

published on 11/06/2024 at 10:02, 14 days 23 hours ago

Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024
Heidelberg Pharma AG to present promising new clinical data on lead ADC-candidate HDP-101 at ASH Annual Meeting 2024, showcasing potential for multiple myeloma treatment

Clinical Data HDP-101 Heidelberg Pharma AG ADC ASH Annual Meeting
BRIEF

published on 10/24/2024 at 11:08, 27 days 22 hours ago

Heidelberg Pharma présentera ses innovations ADC en novembre 2024

Heidelberg Pharma HDP-101 Thérapie Contre Le Cancer ADC HDP-201
BRIEF

published on 10/24/2024 at 11:08, 27 days 22 hours ago

Heidelberg Pharma to Showcase Its ADC Innovations in November 2024

Cancer Therapy Heidelberg Pharma HDP-101 ADCs HDP-201
PRESS RELEASE

published on 10/24/2024 at 11:03, 27 days 22 hours ago

Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024
Heidelberg Pharma to present ADC candidates at scientific and financial conferences in November 2024. Updates on Amanitin-based HDP-101 and Exatecan-based HDP-201. Key targets and conference details

Heidelberg Pharma Scientific Conferences ADC Candidates Amanitin Exatecan
BRIEF

published on 10/10/2024 at 07:11, 1 month 11 days ago

Rapport intermédiaire de Heidelberg Pharma AG pour les neuf premiers mois de 2024

Rapport Financier Heidelberg Pharma Résultats Cliniques Essai Du HDP-101 Vente De Redevances
BRIEF

published on 10/10/2024 at 07:11, 1 month 11 days ago

Heidelberg Pharma AG's Interim Report for First Nine Months of 2024

Financial Report Heidelberg Pharma HDP-101 Trial Clinical Outcomes Royalty Sale
PRESS RELEASE

published on 10/10/2024 at 07:06, 1 month 11 days ago

Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
Heidelberg Pharma AG provides insights on its operational progress and financial figures for the first nine months of fiscal year 2024. Development activities, new clinical data, R&D webinars, and guidance updates are highlighted

Financial Figures Clinical Data Heidelberg Pharma AG R&D Webinars Guidance Updates
BRIEF

published on 10/01/2024 at 17:34, 1 month 19 days ago

Heidelberg Pharma Presents Promising Clinical Data for Lead ADC Candidate HDP-101

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma ADC

1 2 ... 7

Accesswire

Published on 11/21/2024 at 09:00, 50 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 15 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 25 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 50 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 50 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:41, 9 minutes ago

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 09:01, 49 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 50 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 50 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 35 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 52 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 52 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 52 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 42 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 30 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE